Where the math is defensible.
Long-form research on live enterprise decisions. Publication is selective. Every number traces to a named source. No takes without evidence.
Aluminum smelting and tariff architecture 2026: Section 232, the LME Russia ban, and the new premium geography
Primary aluminum links trade defense, sanctions enforcement, and a power constrained smelter map. We map the 71 million tonne supply system, the Section 232 stack, the LME Russia ban, and the 2026 to 2030 corridor.
Global primary aluminum production reached roughly 71 million tonnes in 2024 (IAI), with China near 43 million tonnes against its 45 million tonne cap, the GCC near 6, India above 4, Canada at 3, and Russia at 3.7 from Rusal. The trade system around that base has been rewritten in 24 months. The LME banned Russian metal produced after Apr...
USMCA Article 34.7: The July 2026 Review and the Renegotiation Already Underway
The first six-year joint review opens July 2026. Trump's tariff threats, Sheinbaum's Plan Mexico, automotive rules of origin, and a Mexico-now-largest US trade partner make this the most consequential trilateral negotiation since 1994.
USMCA Article 34.7 mandates a joint review six years after entry into force. The first review opens July 2026. Failure of all three parties to affirm continuation triggers a 16 year sunset window. The 2024 to 2025 backdrop has shifted the negotiation: US merchandise trade with Mexico reached USD 798 billion in 2024 per the US Census Burea...
Section 232 metals review 2026: steel, aluminum, and the next round
Eight years after Proclamations 9704 and 9705, the Section 232 framework on steel and aluminum is heading into a 2026 review that will reshape exclusions, expand product coverage, and tighten the seam with BIS export controls.
Section 232 tariffs of 25 percent on steel and 10 percent on aluminum have now operated for nearly a decade, evolving from blanket measures into a patchwork of country deals, tariff rate quotas, and product exclusions. The 2026 review window opens against a backdrop of persistent global overcapacity, sharper BIS export controls on critica...
The 2026 tariff playbook: layered overlays, real exposures
The 2026 US tariff regime is not one policy. It is six overlapping overlays stacked on top of MFN duties, with effective rates that depend on origin classification, content thresholds, and the antidumping order book. The interesting question is not the headline rate, it is which overlay binds for a given product and supplier.
By the spring of 2026 the US import-duty stack runs at least six overlays deep. Section 301 China duties remain in force at the post-September 2024 USTR review schedule, with EV duties at 100 percent and lithium-ion EV battery duties at 25 percent. IRA Section 30D and Section 48D rules have moved foreign entity of concern enforcement from...
United States and China tariff trajectory through 2026: Section 301, the April reciprocal framework, and the Phase One legacy
The 2024 USTR four year review, the April 2025 reciprocal escalation, and the May 2025 de-escalation framework rebuilt the tariff stack on Chinese imports. We map the Section 301 architecture, the bilateral trade collapse, China retaliation, and the deal, freeze, escalate scenarios into 2026.
United States goods imports from China fell from a 2018 peak of 538 billion US dollars to 438 billion in 2024 (US Census Bureau), with the China share of total US goods imports compressed from 21.6 percent in 2017 to 13.4 percent in 2024. The Section 301 stack moved through three phases: the original 2018 to 2019 lists, the May 2024 USTR ...
Trump pharma tariffs and the US drug supply chain through 2026: Section 232, Ireland exposure, and the API reshoring arithmetic
The April 2025 Section 232 pharmaceuticals investigation, the Ireland headline import number, and the India and China API base together define the 2026 corridor. We map the import stack, the announced reshoring capex, the IRA Year 2 negotiation list, and the 2026 to 2028 buyer playbook.
The Trump administration commenced a Section 232 pharmaceuticals investigation on April 1, 2025 under the Bureau of Industry and Security (BIS) at the Department of Commerce, with public threats of duties between 25 and 200 percent on imported finished drugs and active pharmaceutical ingredients (APIs). United States imports under Harmoni...
Korea's 11th BPLE in 2026: nuclear, renewables, and the KEPCO balance sheet
The 11th Basic Plan for Long term Electricity Supply locks in a higher nuclear share alongside accelerated renewables, but the speed of the transition is constrained less by policy ambition than by KEPCO's wrecked balance sheet and the unresolved tariff politics behind it.
South Korea finalized its 11th Basic Plan for Long term Electricity Supply (BPLE) in early 2025 and entered the implementation phase under a new administration in 2026. The plan targets a 35.6 percent nuclear share and a 32.9 percent clean and renewable share by 2038, anchored by Hanul, Sin Hanul, and a domestic SMR pilot. The execution c...